Director of the Centers for Disease Control and Prevention

Director of the Centers for Disease Control and Prevention
Post	Director of the Centers for Disease Control and Prevention
Body	United States Department of Health and Human Services
Incumbent	Rochelle Walensky
Incumbentsince	2021
Formation	1946
Inaugural	Maurice Hilleman

Contents

Director of the Centers for Disease Control and Prevention

The Director of the Centers for Disease Control and Prevention is the chief executive of the Centers for Disease Control and Prevention and the principal public health official within the United States Department of Health and Human Services, responsible for leading national responses to infectious disease outbreaks, chronic disease prevention, and public health research, and coordinating with agencies such as the National Institutes of Health, the Food and Drug Administration, the Department of Defense, and international partners including the World Health Organization, the Pan American Health Organization, and the European Centre for Disease Prevention and Control.

History

The office traces its origins to the Communicable Disease Center established in 1946 in Atlanta, Georgia as part of efforts by Surgeon General of the United States initiatives and post-World War II public health expansion under the United States Public Health Service, evolving through the tuberculosis and malaria control campaigns that involved figures from CDC collaborations with the Office of Malaria Control in War Areas, the National Institutes of Health, and state health departments such as the Georgia Department of Public Health and the California Department of Public Health. Throughout the Cold War era and the HIV/AIDS epidemic, Directors coordinated with the National Advisory Committee for Aeronautics legacy institutions and with international treaty partners like signatories to the International Health Regulations and engaged with research hubs including Johns Hopkins University, Harvard University, Emory University, and the University of California, Berkeley.

The Director is appointed by the President of the United States and typically confirmed by the United States Senate, sometimes serving in an acting capacity under statutes involving the Federal Vacancies Reform Act of 1998 and receiving oversight from the Office of Management and Budget and the United States Government Accountability Office. Tenure has varied across administrations from long-serving public health leaders connected to institutions such as CDC predecessor agencies to shorter appointments linked to administrations including Reagan administration, Clinton administration, Bush administration, Obama administration, Trump administration, and Biden administration. The Director's removal or replacement can involve interactions with the White House Chief of Staff, congressional oversight hearings before the United States House Committee on Energy and Commerce, and confirmation processes involving majorities in the United States Senate.

A chronological list of Directors includes individuals linked to major public health milestones and institutions such as Maurice Hilleman, William H. Foege, David Sencer, Julie Gerberding, Tom Frieden, Robert R. Redfield, and Rochelle Walensky, each associated with specific programs at the Centers for Disease Control and Prevention and collaborations with entities like the World Health Organization, Pan American Health Organization, National Institutes of Health, and academic centers including Emory University and Johns Hopkins University.

Notable Directors led initiatives including William H. Foege's work on smallpox eradication in coordination with the World Health Organization and the Smallpox Eradication Programme, David Sencer's expansion of immunization and occupational health programs working with the National Institute for Occupational Safety and Health, Julie Gerberding's responses to bioterrorism preparedness after the 2001 anthrax attacks in partnership with the Federal Bureau of Investigation and the Department of Homeland Security, Tom Frieden's initiatives on tobacco control and global health security linked to the Global Health Security Agenda, Robert R. Redfield's work on influenza and HIV collaborations with the National Institute of Allergy and Infectious Diseases, and Rochelle Walensky's leadership during the COVID-19 pandemic including vaccine rollout coordination with the Centers for Disease Control and Prevention, the National Institutes of Health, and pharmaceutical manufacturers such as Pfizer, Moderna, and Johnson & Johnson.

Directors have faced controversies tied to public health policy and crisis management, including debates over responses to the HIV/AIDS epidemic, the 2001 anthrax attacks, the 2009 swine flu pandemic, the Ebola virus epidemic in West Africa (2013–2016), and the COVID-19 pandemic, with scrutiny from entities such as the United States Congress, the Office of Inspector General (United States Department of Health and Human Services), advocacy groups including Human Rights Campaign and Doctors Without Borders, and press coverage in outlets like The New York Times, The Washington Post, and The Wall Street Journal. Criticism has addressed issues of interagency coordination with the Food and Drug Administration, transparency with the United States Senate Committee on Health, Education, Labor, and Pensions, and policy decisions affecting vaccination, quarantine, and travel restrictions involving partners like the World Health Organization and national health ministries including the Ministry of Health (Brazil) and the Ministry of Health and Family Welfare (India).